Advisory Council for the Elimination of Tuberculosis (ACET), 6402 [2010-2768]

Download as PDF 6402 Federal Register / Vol. 75, No. 26 / Tuesday, February 9, 2010 / Notices II. Electronic Access Persons with access to the Internet may obtain the documents at https:// www.fda.gov/BiologicsBloodVaccines/ BloodBloodProducts/Approved Products/PremarketApprovalsPMAs/ ucm185249.htm Dated: February 4, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2010–2757 Filed 2–8–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Marketing (BSC, NCHM) Cprice-sewell on DSK2BSOYB1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 9 a.m.–5 p.m., February 25, 2010. 8:30 a.m.–1 p.m., February 26, 2010. Place: CDC, 2400 Century Parkway, Building 2400, Room 1A (1023), Atlanta, Georgia 30345. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 60 people. The toll free dial-in number is 1 (877) 617–5977 with a pass code of 3468113. Purpose: The Secretary, Department of Health and Human Services (HHS), and, by delegation, the Director, CDC, are authorized under Section 301 (42 U.S.C. 241) and Section 311 (42 U.S.C. 243) of the Public Health Service Act (PHSA), as amended to: Develop and implement disease prevention and control, environmental health, and health promotion and health education activities designed to improve the health of the people of the United States. Under these and additional PHSA and other authorities, CDC acts by identifying and defining preventable health problems, maintaining active surveillance of diseases through epidemiologic and laboratory investigations and data collection, analysis, and distribution; conducting operational research aimed at developing and testing effective disease prevention, control, and health promotion programs; administering a national occupational safety and health program; controlling the introduction and spread of infectious diseases, and providing consultation and assistance to other nations and international agencies to assist in improving their disease prevention and control, environmental health, and health promotion activities. CDC carries out these VerDate Nov<24>2008 14:39 Feb 08, 2010 Jkt 220001 functions through a number of National Centers, Institutes and Offices with expertise and responsibilities in specific areas. Matters To Be Discussed: The agenda will include: A discussion of the recent organizational changes at CDC, specifically presentations on the vision, mission, goals and organizational structure of the new Office of Communications; discussions on program activities, including scientific programs, that will enable the board to provide recommendations and advice on the future course for health communications and marketing at CDC; and a discussion of focus areas and new ideas to implement and expand health marketing science at CDC. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Dionne R. Mason, Committee Management Specialist, NCHM, CDC, 1600 Clifton Road, NE., Mail Stop E–21, Atlanta, Georgia 30333; Telephone: (404) 498–2314, Fax (404) 498– 2221; E-mail: zsu0@cdc.gov. The deadline for notification of attendance is February 17, 2010. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters To Be Discussed: Agenda items include issues pertaining to regionalization of tuberculosis care; the role of genetics in tuberculosis; tuberculosis control updates from the U.S. affiliated Pacific Islands; tuberculosis research updates; and other related tuberculosis issues. Agenda items are subject to change as priorities dictate. For More Information Contact: Margie Scott-Cseh, CDC, 1600 Clifton Road, NE., Mail Stop E–07, Atlanta, Georgia 30333, telephone (404) 639–8317. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 1, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2010–2766 Filed 2–8–10; 8:45 am] Fogarty International Center; Notice of Meeting BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis (ACET) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–5:30 p.m., March 2, 2010. 8:30 a.m.–2:30 p.m., March 3, 2010. Place: CDC, Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333, telephone (404) 639–8317. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Dated: February 1, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–2768 Filed 2–8–10; 8:45 am] BILLING CODE 4163–18–P National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Fogarty International Center Advisory Board. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Fogarty International Center Advisory Board. E:\FR\FM\09FEN1.SGM 09FEN1

Agencies

[Federal Register Volume 75, Number 26 (Tuesday, February 9, 2010)]
[Notices]
[Page 6402]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2768]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis (ACET)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

    Times and Dates: 8:30 a.m.-5:30 p.m., March 2, 2010. 8:30 a.m.-
2:30 p.m., March 3, 2010.
    Place: CDC, Corporate Square, Building 8, 1st Floor Conference 
Room, Atlanta, Georgia 30333, telephone (404) 639-8317.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This council advises and makes recommendations to the 
Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis. Specifically, the Council makes recommendations 
regarding policies, strategies, objectives, and priorities; 
addresses the development and application of new technologies; and 
reviews the extent to which progress has been made toward 
eliminating tuberculosis.
    Matters To Be Discussed: Agenda items include issues pertaining 
to regionalization of tuberculosis care; the role of genetics in 
tuberculosis; tuberculosis control updates from the U.S. affiliated 
Pacific Islands; tuberculosis research updates; and other related 
tuberculosis issues.
    Agenda items are subject to change as priorities dictate.
    For More Information Contact: Margie Scott-Cseh, CDC, 1600 
Clifton Road, NE., Mail Stop E-07, Atlanta, Georgia 30333, telephone 
(404) 639-8317.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 1, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-2768 Filed 2-8-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.